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A subset of proteins targeted by the N-end rule pathway bear degradation signals called N-degrons, whose
determinants include destabilizing N-terminal residues. Our previous work identified mouse UBR1 and UBR2
as E3 ubiquitin ligases that recognize N-degrons. Such E3s are called N-recognins. We report here that while
double-mutant UBR1/ UBR2/ mice die as early embryos, the rescued UBR1/ UBR2/ fibroblasts still
retain the N-end rule pathway, albeit of lower activity than that of wild-type fibroblasts. An affinity assay for
proteins that bind to destabilizing N-terminal residues has identified, in addition to UBR1 and UBR2, a huge
(570 kDa) mouse protein, termed UBR4, and also the 300-kDa UBR5, a previously characterized mammalian
E3 known as EDD/hHYD. UBR1, UBR2, UBR4, and UBR5 shared a 70-amino-acid zinc finger-like domain
termed the UBR box. The mammalian genome encodes at least seven UBR box-containing proteins, which we
propose to call UBR1 to UBR7. UBR1/ UBR2/ fibroblasts that have been made deficient in UBR4 as well
(through RNA interference) were significantly impaired in the degradation of N-end rule substrates such as the
Sindbis virus RNA polymerase nsP4 (bearing N-terminal Tyr) and the human immunodeficiency virus type 1
integrase (bearing N-terminal Phe). Our results establish the UBR box family as a unique class of E3 proteins
that recognize N-degrons or structurally related determinants for ubiquitin-dependent proteolysis and perhaps
other processes as well.
Protein degradation by the ubiquitin (Ub) system controls
the levels of many intracellular proteins. A substrate of the Ub
system is conjugated to Ub through the action of three en-
zymes, E1, E2, and E3 (13, 23, 30, 59, 60). A ubiquitylated
protein bears a covalently linked poly-Ub chain and is de-
graded by the 26S proteasome (7, 63, 83). The selectivity of
ubiquitylation is determined mainly by E3, which recognizes a
substrate’s degradation signal (degron) (2, 3, 21, 30, 48, 60).
The term Ub ligase denotes either an E2-E3 holoenzyme or its
E3 component. The E3 proteins are an exceptionally large
family, with more than 500 distinct E3s in a mammal (13, 59,
60). An essential determinant of one class of degrons, called
N-degrons, is a substrate’s destabilizing N-terminal residue.
The set of destabilizing residues in a given cell type yields a
rule, called the N-end rule, which relates the in vivo half-life of
a protein to the identity of its N-terminal residue (2, 46, 78).
An N-degron consists of two major determinants: a destabiliz-
ing N-terminal residue of a protein substrate and its internal
Lys residue(s) (71, 78). The latter is the site of formation of a
substrate-linked poly-Ub chain (14, 61).
The N-end rule has a hierarchic structure (Fig. 1A). Specif-
ically, N-terminal Asn and Gln are tertiary destabilizing resi-
dues in that they function through their deamidation, by N-
terminal amidohydrolases (5, 41), to yield the secondary
destabilizing N-terminal residues Asp and Glu (Fig. 1A). The
activity of Asp and Glu requires their conjugation, by ATE1-
encoded isoforms of Arg-tRNA-protein transferase (R-trans-
ferase), to Arg, one of the primary destabilizing residues (42,
43). The latter are recognized by E3 Ub ligases of the N-end
rule pathway, which target a substrate for Ub-dependent deg-
radation by the 26S proteasome (22, 46, 47, 74, 78, 85) (Fig.
1A). In mammals, the set of N-end rule destabilizing residues
that function through their arginylation contains not only Asp
and Glu but also Cys, which is a stabilizing (unarginylated)
residue in the yeast Saccharomyces cerevisiae (3, 25, 42). The
arginylation of N-terminal Cys is preceded by its oxidation (42)
(R. G. Hu, J. Sheng, X. Qi, Z. Xu, T. Takahashi, and A.
Varshavsky, unpublished data).
The N-end rule pathway is present in all eukaryotes exam-
ined so far, from animals and plants to fungi. It is also present
in prokaryotes, despite their lacking both Ub conjugation and
Ub itself (25, 46, 70, 73, 78). The known functions of the N-end
rule pathway include the control of peptide import (through
conditional degradation of the import’s repressor) (22, 74), the
fidelity of chromosome segregation (through degradation of a
conditionally produced cohesin’s fragment) (62), the regula-
tion of apoptosis (through degradation of a caspase-processed
inhibitor of apoptosis) (20, 77), as well as regulation of meiosis
in yeasts and metazoans (6, 38, 46), leaf senescence in plants
(89), and cardiovascular development in mammals (42). The
pathway’s function in cardiovascular development is likely to
be mediated, at least in part, by the arginylation-dependent
degradation of RGS4, RGS5, and RGS16, a set of GTPase-
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FIG. 1. Construction and analysis of UBR1/ UBR2/ cells. (A) The mammalian N-end rule pathway. N-terminal residues are indicated by
single-letter abbreviations for amino acids. The ovals denote the rest of a protein substrate. (B) Southern analysis of UBR1 and UBR2 using
wild-type (wt) and UBR1/ UBR2/ embryos with cDNA probes (46, 47). To determine UBR1 genotypes, DNAs from EFs were digested with
SphI (5 probe) or BamHI (3 probe). To determine UBR2 genotypes, embryonic DNAs were digested with NheI (5 probe) or BamHI/SalI (3
probe). (C) Northern analysis of UBR1 and UBR2 using total RNAs from UBR1/ UBR2/ and UBR1/ UBR2/ EFs. Different UBR1 and
UBR2 cDNA fragments were used to probe the deleted regions in the knockout alleles (deleted) or both the deleted regions and its flanking regions
(flanking) as described (46, 47). The two different UBR2 probes detected no significant UBR2 mRNA in UBR1/ UBR2/ EFs, while the UBR1
probe, which encompasses both the deleted region and its 3-flanking region, detected UBR1-specific transcripts in UBR1/ UBR2/ EFs. These
aberrant transcripts appear to be the abnormally spliced RNAs transcribed from the PUBR1 promoter. (D) Design of bead-conjugated synthetic
peptides bearing different N-terminal amino acids. N-terminal residues of bead-conjugated peptide are indicated by three-letter abbreviations. An
11-mer peptide was covalently linked to a bead as described in Materials and Methods. (E) EF cytoplasmic proteins captured by a bead-conjugated
Phe-peptide were separated in SDS-PAGE (5% Tris-glycine gel) and analyzed by immunoblotting (IB) using anti-UBR1 and UBR2 antibodies.
The bottom panel shows immunoblotting analysis of actin for an input control. (F) Primary wild-type and UBR1/ UBR2/ EF cells were
immortalized to increase transfection efficiency, and the resulting immortalized cells were transiently transfected with pcDNA3flagDHFRhaUb-
X-nsP4flag (where X is Met, Arg, or Tyr) expressing fDHFRh-UbR48-X-nsP4f, a UPR-based fusion yielding cotranslationally the fDHFRh-UbR48
reference protein (denoted fDUb on the left) and X-nsP4f test protein (denoted X-nsP4 on the left). Cells were labeled for 12 min with
[35S]methionine/cysteine, followed by a chase for 0, 1, and 2 h in the presence of cycloheximide, preparation of extracts, immunoprecipitation with
anti-Flag M2-agarose (Sigma), SDS-PAGE, autoradiography, and quantitation, essentially as described (46). (G) Quantitation of the patterns in
F using PhosphorImager. The amounts of 35S in an X-nsP4f, relative to 35S in the fDHFRh-UbR48 reference protein at the same time points, were
plotted as percentages of this ratio for Met-nsP4f (bearing a stabilizing N-terminal residue) at time zero. Open and solid symbols denote data
obtained with wild-type and UBR1/ UBR2/ extracts, respectively. E, Met-nsP4; ‚, Tyr-nsP4; , Arg-nsP4.
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activating proteins that down-regulate signaling by specific G
proteins and are themselves targeted by the N-end rule path-
way (17) (M. J. Lee, T. Tasaki, J. Y. An, K. Moroi, I. Vavydov,
and Y. T. Kwon, unpublished data; R. G. Hu, J. Sheng, X. Qi,
Z. Xu, T. Takahashi, and A. Varshavsky, unpublished data).
Other substrates of the N-end rule pathway (in addition to
those mentioned above) include RNA polymerases of alpha-
viruses (18); the integrase of the human immunodeficiency
virus type 1 (HIV-1) (56); a protein called p60, secreted by the
bacterium Listeria monocytogenes into the host cell’s cytosol
(68); the 3C protease of encephalomyocarditis virus (49); and
a subset of 2 subunits of mammalian G proteins (27). The
functions of the N-end rule pathway in controlling the levels of
these proteins remain to be understood. In addition, the results
of studies in which dipeptides with destabilizing N-terminal
residues were used to perturb the N-end rule pathway sug-
gested its involvement in cell differentiation (32, 58), turnover
of muscle proteins (69), and limb regeneration in amphibians
(72).
The E3 Ub ligases that recognize N-degrons are called N-
recognins (6, 78). UBR1, the S. cerevisiae N-recognin, is a
225-kDa RING-type E3 containing at least three substrate-
binding sites. The type 1 site binds to basic N-terminal residues
(Arg, Lys, and His) of either protein-sized N-end rule sub-
strates or short peptides. The type 2 site binds to bulky hydro-
phobic N-terminal residues (Leu, Ile, Phe, Tyr, and Trp) (6,
78). The third binding site of S. cerevisiae UBR1 targets sub-
strates through their internal (non-N-terminal) degrons, and is
allosterically “activated” through perturbation of autoinhibited
UBR1 conformation by peptides with destabilizing N-terminal
residues that bind to UBR1 at its type 1 and type 2 sites (22,
74). The only known substrate of the yeast N-end rule pathway
that is targeted through the third binding site of UBR1 is
CUP9, a transcriptional repressor that down-regulates PTR2
(encoding a peptide transporter) and several other genes as
well (22, 74).
Our previous studies identified and characterized mamma-
lian E3s termed UBR1 and UBR2 (45–47), two sequelogs of S.
cerevisiae UBR1 (sequelog and spalog are evolutionarily neu-
tral terms denoting a sequence that is similar to a specified
extent to another sequence and a three-dimensional structure
that is similar to a specified extent to another three-dimen-
sional structure, respectively [79]). UBR2 was also character-
ized by another group (40). The mouse UBR1 and UBR2 are
functionally overlapping 200-kDa N-recognins with 47% iden-
tity and 68% similarity to each other. Their binding specificities
to destabilizing N-terminal residues of proteins or short pep-
tides are indistinguishable from each other in nonquantitative
assays (46, 47). Human UBR1 and UBR2 in HeLa cells were
found to interact with RECQL4, a putative helicase that is
mutated in patients with the Rothmund-Thomson and
RAPADILINO syndromes, a set of recessively inherited ill-
nesses whose multiple manifestations include predisposition to
cancer (88). The currently characterized interaction of
RECQL4 with UBR1 and UBR2 does not confer a short
half-life on RECQL4 (88).
Previously constructed UBR1/ mice were viable but dif-
ferent from their wild-type littermates in several ways that
remain to be understood mechanistically (47). By contrast,
UBR2/ mice, in some of the strain backgrounds examined,
exhibited gender-dependent lethality in that most UBR2/
females died during embryogenesis, while UBR2/ males
were viable but infertile owing to postnatal apoptosis of sper-
matocytes (46).
In the present work, we further addressed the functions of
UBR1 and UBR2 by constructing double-mutant UBR1/
UBR2/ mouse strains. These mice, in contrast to their single-
mutant counterparts, died as early embryos. We also charac-
terized the N-end rule pathway in fibroblasts derived from
UBR1/ UBR2/ embryos and found that these cells, de-
spite lacking the pathway’s known Ub ligases, retained a sig-
nificant fraction of the pathway’s activity. We then employed
an affinity assay and proteomic methods to search for other
mouse N-recognins, identifying an exceptionally large (570-
kDa) protein, termed UBR4, and the 300-kDa UBR5, a pre-
viously characterized mammalian E3 known as EDD/hHYD
(11, 29, 31, 65). Strong sequelogs (79) of mammalian UBR4
are known as PUSHOVER in Drosophila melanogaster and as
BIG in plants (19, 24, 37, 52, 54, 64, 87). RNA interference
(RNAi) was used to make UBR1/ UBR2/ fibroblasts also
deficient in UBR4. The resulting cells were impaired in the
degradation of N-end rule substrates. The recognition of de-
stabilizing N-terminal residues by UBR4 and UBR5 is a new
property of these proteins. UBR1, UBR2, UBR4, UBR5, and
at least three other mouse proteins contain a distinct motif that
we propose to call the UBR box. The resulting UBR box family
consists of either demonstrated or inferred ubiquitin ligases. A
major part of this family are E3s of the N-end rule pathway.
MATERIALS AND METHODS
Construction of UBR1/ UBR2/ mouse strains and isolation of UBR1/
UBR2/ fibroblasts. Mouse UBR1 and UBR2 are located on chromosomes 2
and 17, respectively (45, 46). UBR1/ and UBR2/ mice, in the 129SvImJ/
C57BL/6 genetic background, were crossed to produce compound-heterozygous
UBR1/ UBR2/ mice. The latter were intercrossed to produce, among other
genotypes, the UBR1/ UBR2/ progeny. Construction and characterization
of UBR1/ and UBR2/ mice was described (46, 47).
Primary embryonic fibroblasts (EFs) were established from E11.5 UBR1/
UBR2/ embryos and their UBR1/ UBR2/ littermates, as described (46,
47). Permanent cell lines were established from primary EFs through crisis-
mediated immortalization, by replating cell cultures over2 months (1.5 106
cells onto a 10-cm plate every 3 days). DNA transfection efficiency was consid-
erably higher with immortalized EFs than with primary EFs.
Antibodies. Chicken polyclonal antibodies to mouse UBR4 were produced by
Gallus Immunotech Inc. (Ontario, Canada) against synthetic peptides CSFEKY
DEDHSGDDK (residues 4615 to 4629; antibody UBR4-119R) and
DLDGEDEKDKGALDC (residues 2982 to 2995, plus an additional C-terminal
Cys; antibody UBR4-244). Rabbit (peptide-mediated) polyclonal antibodies to
mouse UBR1 and UBR2 were produced and characterized as described (46, 47).
Mouse monoclonal antibodies to N-terminal and C-terminal regions of HIV-1
integrase were a gift from Dag Helland (University of Bergen, Norway). Anti-V5
epitope antibody was purchased from Invitrogen (Carlsbad, CA). Rabbit anti-
bodies to mouse UBR5/EDD/hHYD and to green fluorescent protein (GFP)
were from Santa Cruz Biotechnology (Santa Cruz, CA) and Abcam (Cambridge,
MA), respectively. Antibody to Drosophila Hyperplastic disks (dHYD/dUBR5)
was a gift from Allen Shearn (Johns Hopkins University, Baltimore, MD). Rab-
bit antiactin antibody was from Sigma. Anti-Ub antibody (Biomol International,
Plymouth Meeting, PA) binds to both mono- and polyubiquitylated proteins, but
not to free Ub. Secondary antibodies were from Bio-Rad (Hercules, CA) and
Santa Cruz Biotechnology.
Northern hybridization analysis. Mouse adult tissue RNA blot (Seegene,
Seoul, Korea) was hybridized with 32P-labeled cDNA fragments of mouse UBR4
or human -actin. The UBR4 cDNA probe (1,269 bp) was amplified by PCR,
using the primers 5-CACCATGGTTCCCACCTTAGGCTCAC (forward) and
5-TGTGCGGGCTGTGATGGTAGCTG (reverse).
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In vivo protein degradation assay and plasmids. Immortalized EF cells were
transiently transfected, using Lipofectamine 2000 (Invitrogen), with plasmids
expressing test substrates. About 24 h after transfection, cells were labeled for 10
min at 37°C with [35S]methionine/cysteine (35S-Express, Perkin-Elmer, Boston,
MA), followed by a chase in the presence of cycloheximide, preparation of
extracts, immunoprecipitation, NuPAGE 10%-bis-Tris sodium dodecyl sulfate
(SDS)-polyacrylamide gel electrophoresis (PAGE) (Invitrogen), autoradiogra-
phy, and quantitation of 35S by Molecular Imager FX system (Bio-Rad), essen-
tially as described (41, 43).
To determine in vivo decay curves of X-nsP4 (where X is Met, Arg, Tyr, His,
Phe, Gly, Leu, or Thr), cells were transfected with plasmids expressing X-nsP4
from the cytomegalovirus promoter (PCMV), with X-nsP4 as part of the fDHFRh-
UbR48-X-nsP4f fusion (superscripts h and f denote the hemagglutinin and Flag
epitopes, respectively), a UPR (Ub/protein/reference) construct (47). This fusion,
fDHFRh-UbR48-X-nsP4f, is cotranslationally cleaved by deubiquitylating en-
zymes at the UbR48-X junction, yielding the long-lived fDHFRh-UbR48 reference
protein and X-nsP4f, a test protein. In the UPR technique, the reference protein
serves as an internal control for levels of expression, immunoprecipitation yields,
sample volumes, and other sources of sample-to-sample variation (46, 51, 71, 74,
75, 80). fDHFRh-UbR48-X-nsP4f plasmids were constructed by subcloning PCR-
produced SmaI-XbaI fragments encoding X-nsP4f into the EheI- and XbaI-cut
UPR vector pcDNA3(dEheI)FDHUMCM (J. Sheng and A. Varshavsky, unpub-
lished data) encoding fDHFRh-UbR48. Parameters of X-nsP4 degradation in EF
cells were calculated as described (51).
The set of pEGFP-IRES-Ub-X-integrase (where X is Met, Gly, Arg, His, Leu,
or Phe) plasmids expressing the enhanced green fluorescent protein (EGFP)
reference protein and X-integrase (see Fig. 7A) were described previously (56).
The pcDNA3-Ub-X-INMOD-IRES-hrGFP (where X is Met and Phe) plasmids
were constructed by ligating the Ub open reading frame (ORF) to a synthetic
version of the HIV-1 integrase gene (AF422697; Met or Phe at position 1 of
integrase) and then aligning an internal ribosome entry site element with the
humanized recombinant Renilla leniformis green fluorescent protein ORF (Strat-
agene, La Jolla, CA) such that a single transcriptional unit was specified.
To examine steady-state levels of X-integrase, cells were transfected with one
of the above plasmids and incubated for 1.5 h (12 h after transfection) in the
presence or absence of the proteasome inhibitor MG132 (EMD Biosciences, La
Jolla, CA). Cells were lysed in 1% Nonidet-P40 (NP-40), 0.15 M NaCl, 1 mM
EDTA, 10 mM Tris-HCl (pH 7.5), and the lysates were incubated with mono-
clonal antibody to HIV-1 integrase. Immunocomplexes were recovered using
protein G-agarose (Amersham Bioscience, Piscataway, NJ) and analyzed using
NuPAGE 10%-Bis-Tris gel (Invitrogen), followed by immunoblotting with the
same antibody. Lysates were also subjected to immunoblotting with anti-GFP
antibody. For pulse-chase analysis of X-integrase, plasmid pcDNA3.1D/V5-His/
lacZ (Invitrogen) encoding -galactosidase-V5-His was cotransfected to normal-
ize the level of 35S-labeled X-integrase.
In vitro transcription-translation-degradation assay. The test protein was
expressed in 25 l of TNT Quick-coupled transcription-translation system (Pro-
mega, Madison, WI) containing a rabbit reticulocyte lysate premixed with most
of the reaction components necessary to carry out transcription/translation in the
lysate. X-integrase was labeled with [35S]methionine (Amersham Bioscience). A
2-l aliquot of the reaction was taken out at each time point and mixed with 8 l
of SDS sample loading buffer, followed by SDS-PAGE and autoradiography.
X-nsP4 was labeled with biotin by adding biotinylated lysine-tRNA complex in
the reaction (Transcend tRNA, Promega). To detect biotinylated X-nsP4, the
blotted membrane was incubated with horseradish peroxidase-conjugated
streptavidin (Pierce), followed by enhanced chemiluminescence. The reaction
mixtures containing dipeptides also contained 0.15 mM bestatin (Sigma), an
inhibitor of some aminopeptidases, to reduce degradation of the added dipep-
tides (47).
Peptide-based pulldown assay. For affinity-based identification of mouse N-
recognins, peptides X-Ile-Phe-Ser-Thr-Asp-Thr-Gly-Pro-Gly-Gly-Cys (where X
is Arg, Phe, Gly, Ser, Thr, Ala, Asp, or Met) were synthesized (Fig. 1D). The
sequence of residues 2 to 9 of these peptides was identical to that of Sindbis virus
polymerase (nsP4) at the same positions. The peptide was cross-linked, via its
C-terminal Cys residue, to UltraLink Iodoacetyl beads (Pierce, Rockford, IL), as
described (22). Testes and brains were collected from 2- to 6-month-old male
C57BL6/J mice (Charles River, Wilmington, MA) and frozen immediately in
liquid N2. The tissues were homogenized in buffer A (10% glycerol, 75 mM KCl,
0.1 mM EDTA, 20 mM HEPES, pH 7.9) containing protease inhibitors (Sigma),
and a soluble fraction was prepared by a two-step centrifugation, at 9,000  g for
20 min and at 100,000  g for 1 h.
Cytoplasmic extracts of EFs and D.Mel-2 cell (ATCC CRL 1963) were pre-
pared as described (88). Extracts were diluted to 2 mg ml 1 of protein in buffer
B (0.05% Tween 20, 10% glycerol, 0.2 M KCl, 20 mM HEPES, pH 7.9). In some
experiments with cytoplasmic extracts, buffer C (0.1% NP-40, 10% glycerol, 0.15
M KCl, 20 mM HEPES, pH 7.9) was used instead of buffer B. Peptide-linked
beads (15-l packed volume) were incubated in 1 ml of tissue or cytoplasmic
extracts diluted with buffer B (2 mg of total protein) at 4°C for 12 h. The beads
were pelleted by centrifugation in a microcentrifuge at 2,500 rpm for 30 seconds,
washed four times with 0.5 ml of buffer B, resuspended in 70 l of SDS-PAGE
sample buffer containing 0.1 M dithiothreitol, and heated at 70°C for 10 min. For
analysis by mass spectrometry, the beads were heated at 56°C for 30 min. For
elution with dipeptides, the above washed (by buffer B) beads were washed again
with buffer D (75 mM NaCl, 20 mM HEPES, pH 7.9) and incubated with 0.25 ml
of 25 mM dipeptide (Phe-Ala or Ala-Phe; Bachem, King of Prussia, PA) for 10
min on ice. After pelleting the beads, the supernatants were pooled and con-
centrated using Microcon YM-10 (Millipore, Bedford, MA).
Mass spectrometry. Silver staining of SDS-PAGE gels was performed accord-
ing to an online protocol (http://www.healthsystem.virginia.edu/internet/bio
molec/Silverstains.cfm). For mass spectrometry, separated proteins were blotted
onto a polyvinylidene difluoride membrane (Problott, Applied Biosystems, Fos-
ter City, CA) and stained using the colloidal gold method (Bio-Rad). The
immobilized proteins were reduced, S-carboxymethylated, and digested in situ
with Achromobacter protease I (Lys-C), which cleaves after Lys (33). Mass
spectrometry analyses of protein fragments were performed by matrix-assisted
laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry us-
ing a PerSeptive Biosystem Voyager-Delayed Extraction/RP (35). Proteins were
identified by comparing molecular masses determined by mass spectrometry with
molecular masses derived from sequence databases.
RNAi. RNAi was carried out essentially as described (9). Four 19-nucleotide
sequences were chosen from the mouse UBR4 ORF, using the Whitehead siRNA
Selection Web Server (http://jura.wi.mit.edu/bioc/siRNA) (91). Four pairs of
64-nucleotide oligonucleotides including a 9-nucleotide hairpin spacer (5-TTC
AAGAGA-3) were synthesized (MWG Biotech, High Point, NC), annealed,
and subcloned into a BglII- and HindIII-cleaved retroviral vector pSUPER.ret-
ro.puro (OligoEngine, Seattle, WA). The target sequences used were A (nucle-
otides 202 to 224, 5-GCAGTACGAGCCGTTCTA-3), B (nucleotides 5083 to
5105, 5-GGTATGCCATAAGGACCAT-3), C (nucleotides 8149 to 8171, 5-C
AAGCGGAGACACGTGACG-3), and D (nucleotides 13690 to 13712, 5-GG
ATCAACTGGTGATGCTC-3), yielding plasmids pSUPER-A to pSUPER-D,
respectively. A control plasmid (pSUPER-Luc) was constructed using a 19-
nucleotide sequence (5-GATTATGTCCGGTTATGTA-3) to target the firefly
luciferase (76).
Ecotropic retroviruses for transduction of mouse cells were obtained by tran-
sient transfection of the retroviral vectors into the packaging cell line Phoenix
Eco (American Type Culture Collection SD3444). Phoenix Eco cells were grown
to 50% confluence in 10-cm culture dishes and then transfected with 4 g of
plasmid DNA using Lipofectamine 2000 (Invitrogen). The medium was replaced
24 h after transfection; the retrovirus-containing medium was collected at 48 h
after transfection and filtered through a 0.45-m filter. Wild-type and UBR1/
UBR2/ EFs were plated on a 10-cm culture dish at 2  105 to 3  105 cells 12
to 18 h prior to infection. The medium was replaced with 4 ml of the infection
cocktail, including 2 ml of retrovirus-containing medium, 4 g ml 1 of Poly-
brene, and a standard medium, followed by incubation for 4 h. A 7-ml aliquot of
standard medium was then added to the cultures, followed by incubation for 44 h.
The infected cells were split onto a new 10-cm dish and cell lines containing
integrated retrovirus were selected with puromycin at 4 to 6 g ml 1 (Sigma).
DNA/protein sequences and alignment analysis. Sequence alignment analysis
was carried out using the T-COFFEE web server (http://www.ch.embnet.org/software
/TCoffee.html) (57). Phylogenetic analyses were performed using MEGA version
2.1 (39).
RESULTS
Construction and characterization of UBR1/ UBR2/
mouse strains and cell lines. The retention of the N-end rule
pathway in the previously produced single-mutant UBR1/
and UBR2/ EF cell lines was consistent with the fact that
both UBR1 and UBR2 are N-recognins and thus functionally
complement one another (46, 47). In the present work, we
used compound heterozygous crosses of UBR1/ UBR2/
mice to produce double-mutant UBR1/ UBR2/ strains,
whose genotype and the absence of wild-type UBR1 and UBR2
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mRNAs were verified by Southern and Northern analyses,
respectively (Fig. 1B and C). In contrast to the viability of
UBR1/ mice and (gender-biased) late-embryonic lethality of
UBR2/ mice (see the introduction), the absence of both
UBR1 and UBR2 resulted in early embryonic lethality. Spe-
cifically, no live UBR1/ UBR2/ embryos were recovered
beyond E11.5, and the recovered double-mutant embryos ex-
hibited multiple morphological and growth abnormalities, in-
cluding defective proliferation of neuroepithelial cells and ap-
parent cardiovascular defects (J. Y. An., T. Tasaki, A.
Varshavsky, and Y. T. Kwon, unpublished data).
To characterize the N-end rule pathway in the absence of
both UBR1 and UBR2 and to produce UBR1/ UBR2/
cells that could be readily transfected with DNA, we estab-
lished EF cell lines from fibroblasts of E11.5 UBR1/
UBR2/ embryos. A previously described, peptide-based pull-
down assay (Fig. 1D) (22, 46) was used to detect either UBR1
or UBR2 in cell extracts through their binding to destabilizing
N-terminal residues of proteins or short peptides. This assay
utilized a set of otherwise identical 12-mer peptides with dif-
ferent N-terminal residues. Each peptide was cross-linked to
microbeads through its C-terminal Cys residue. Immobilized
X-peptides, with X being a varying N-terminal residue, were
incubated with cell extracts, followed by recovery of bound
proteins, SDS-PAGE, and immunoblotting with anti-UBR1 or
anti-UBR2 antibodies (46). The Phe-peptide assay (Phe is a
type 2 primary destabilizing residue) (Fig. 1A) confirmed that
UBR1/ UBR2/ EFs lacked both UBR1 and UBR2, that
UBR1/ EFs lacked UBR1 but not UBR2, and that UBR2/
EFs lacked UBR2 but not UBR1 (Fig. 1E).
Previous work identified the 70-kDa Sindbis virus RNA
polymerase (nsP4) as an N-end rule substrate that is targeted
for degradation, at least in rabbit reticulocyte extract, through
the N-terminal Tyr residue of nsP4 (18). (In vivo, Tyr-bearing
nsP4 is produced through its excision, by a viral protease, from
a polyprotein synthesized during Sindbis virus infection.) X-
nsP4 proteins, produced in vivo using the Ub fusion technique,
are either short-lived or metabolically stable, depending on the
presence of a destabilizing or stabilizing N-terminal residue,
respectively (46, 47). We carried out pulse-chase assays with
UBR1/ UBR2/ versus wild-type EF cells that had been
transiently transfected with plasmids expressing fDHFRh-
UbR48-X-nsP4f fusion proteins, where X was a varied residue.
These reporters are based on the UPR technique (46, 47, 71,
74, 80). The long-lived reference moiety fDHFRh-UbR48,
which serves as a reference protein, is cotranslationally cleaved
from a nascent fDHFRh-UbR48-X-nsP4f fusion by deubiquity-
lating enzymes. Remarkably, despite the absence of both
UBR1 and UBR2, the only two mouse N-recognins known at
the time of analysis, UBR1/ UBR2/ EFs, were found to
contain the N-end rule pathway. Its activity was detectably but
not considerably decreased in UBR1/ UBR2/ EFs relative
to their wild-type counterparts (Fig. 1F and G), suggesting that
the mammalian genome encodes an unknown N-recognin that
recognizes the N-degrons for Ub-dependent proteolysis.
Identification of UBR4 and UBR5/EDD, which can bind to
type 1 and/or type 2 N-degrons. To identify such an E3, we
asked whether there is an additional UBR1/2-like E3. We
identified a previously uncharacterized UBR-homologous pro-
tein, named UBR3, whose complete ORF is currently not
available in the database. We cloned the 8-kb full-length
mouse UBR3 cDNA by conventional cDNA library screening
(T. Tasaki, Y. T. Kwon, and A. Varshavsky, unpublished data).
The 213-kDa UBR3 is a RING-finger E3, shares weak but
detectable homology (22% identity) to UBR1 and UBR2, and
contains several domains conserved in UBR1 and UBR2.
However, UBR3 expressed in S. cerevisiae cells did not bind to
N-degrons (T. Tasaki, Y. T. Kwon, and A. Varshavsky, unpub-
lished data), to which UBR1 and UBR2 readily bound. These
results suggest that the mammalian genome encodes at least
one N-recognin that does not share overall sequence similarity
to UBR1 or UBR2.
We have recently developed a peptide-pulldown assay to
measure the interaction between an overexpressed E3 and
N-degron (Fig. 1A, D, and E) (22, 46). We then asked whether
N-degron-peptide beads could precipitate the proteomic
amounts of endogenous N-recognins from mouse tissue ex-
tracts. The assay employed immobilized X-peptides bearing
N-terminal Arg (a type 1 destabilizing residue), Phe (a type 2
destabilizing residue), Met or Gly (stabilizing residues), Asp
(an ATE1 substrate), or Ala, Ser, or Thr (type 3 destabilizing
residues) (25, 78).
Specific X-peptides were incubated with mouse testis ex-
tracts (Fig. 2A to D) and with extracts from other tissues as
well (data not shown), followed by centrifugation, isolation of
peptide-bound proteins, SDS-PAGE, and silver staining. Silver
staining of precipitates from peptide-based pulldown assays
reproducibly revealed four major proteins that were captured
by type 1 and/or type 2 peptides (Fig. 2A). Proteins blotted on
a polyvinylidene difluoride membrane were visualized by the
colloidal gold staining; MALDI-TOF/mass spectrometry anal-
ysis of Achromobacter protease I-digested proteins identified
them as UBR1, UBR2, and two other proteins termed UBR4
and UBR5 (Fig. 2A).
The first two proteins identified were UBR1 and UBR2,
which we have recently shown to bind to type 1 and type 2
N-degrons by using GST-pulldown assays with overexpressed
UBR1 and UBR2 (46). Notably, endogenous UBR1 and
UBR2 bound more efficiently to N-terminal Phe (a type 2
residue) than to N-terminal Arg (a type 1 residue) (Fig. 1A and
2A), suggesting that these two N-recognins have stronger af-
finity to type 2 than type 1 N-degrons. Quantitative binding
data and functional assays are required to address the potential
significance of this result.
UBR4 is a huge, novel protein, whose complete ORF is not
clear in the database. Based on both the apparent size of
UBR4 on SDS-PAGE (Fig. 2A) and the hypothetical
15,468-bp ORF deduced from the databases on overlapping
cDNA sequences, we conjecture that the 109-kb mouse
UBR4, on chromosome 4, comprises 108 exons and encodes an
exceptionally large protein of 570 kDa. UBR4 appears to be a
sequelog of the 560-kDa Arabidopsis BIG and the 560-kDa
Drosophila PUSHOVER (see Discussion), given similar sizes,
continuous overall homology, and shared domains, including a
unique Cys-rich domain (Fig. 3B) (24, 37, 52, 54, 64, 87).
Among the roles of Arabidopsis UBR4 (BIG) are regulation
of the function and transport of auxin, a major plant hormone
(19, 24, 37, 52, 54). In Drosophila, UBR4 (PUSHOVER) plays
a role in glial cell growth, neuronal excitability, and synaptic
vesicle fusion (64, 87). Northern blot analysis demonstrated
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that UBR4 mRNA is rather broadly expressed in mouse tissues
and embryonic stages, with a higher level in the adult testis and
brain (Fig. 2F). UBR1, UBR2, and UBR4 were reproducibly
retained by Phe-peptide and Arg-peptide (to different extents
for different UBRs; see below), but not by other X-peptides
tested (Fig. 2A), suggesting that these proteins bind to both
type 1 and type 2 N-degrons. A dipeptide bearing type 1 or type
2 N-degron competitively inhibits the in vitro binding of UBR1
and UBR2 to N-degron (46, 47). UBR1, UBR2 and UBR4 that
were bound to the immobilized Phe-peptide could be eluted by
the dipeptide Phe-Ala but not by Gly-Ala, which bore a stabi-
lizing N-terminal residue (Fig. 2B), suggesting that UBR1,
UBR2, and UBR4 may contain a common domain that binds
to N-degrons. The relative amounts of UBR4 retained on
Phe-peptide beads that were incubated with protein concen-
tration-adjusted extracts from either wild-type, UBR1/,
UBR2/, or UBR1/ UBR2/ EF cells did not differ con-
siderably, indicating that the interaction of UBR4 with N-
terminal Phe does not require UBR1/UBR2 and also suggest-
ing that expression of UBR4 is not influenced strongly, if at all,
by the level of UBR1 or UBR2 in a cell (Fig. 2C).
Another mammalian N-recognin identified by the X-peptide
pulldown assay (Fig. 2A) was a 300-kDa protein called EDD
(E3 identified by differential display) (11) or hHYD (31).
EDD/hHYD has been shown to be an HECT-domain E3 Ub
ligase essential for embryogenesis and interacting with a vari-
ety of proteins, including progesterone receptor and a topo-
isomerase-binding protein (29, 31, 65). This protein is a strong
sequelog (79) of the previously characterized Drosophila tumor
suppressor gene hyperplastic disks (55). We termed it UBR5
because its N-degron-binding property specifically classifies
this E3 as a member of the UBR box proteins (see below). The
UBR root is recommended as a standard root for the names of
E3 Ub ligases that recognize N-degrons; see the web site
(http://www.informatics.jax.org/mgihome/nomen) provided by
the Jackson Laboratory, Bar Harbor, Maine. Furthermore,
UBR5 (EDD/hHYD) was captured by type 1 (Arg) but not by
type 2 (Phe) X-peptide beads, a binding pattern distinct from
that of UBR1, UBR2, and UBR4 (Fig. 2A). Thus, UBR5
appears to be an N-recognin specific for type 1 (basic) N-
terminal residues.
To further verify the results from mass spectrometry, we
FIG. 2. Identification of mouse N-recognins. (A) Peptide-pulldown assay using testis extracts and bead-conjugated peptides. Captured proteins
were separated and visualized using silver staining. The identities of four major bands that are specifically and reproducibly captured by Phe- and/or
Arg-peptide beads were determined using peptide mass fingerprinting. (B) UBR1, UBR2, and UBR4 bound from testis extract were eluted from
Phe-peptide beads by the Phe-Ala dipeptide but not by Gly-Ala. (C) The amount of UBR4 bound by Phe-peptide beads from EF cell extracts does
not depend strongly on the presence of UBR1 and/or UBR2. Proteins bound by either mock or Phe-peptide beads are indicated on the left with
short bars: white, UBR1; gray, UBR2; and black, UBR4. (D) Testis proteins bound to bead-conjugated peptides bearing different N-terminal
amino acids were immunoblotted with antibodies against UBR1, UBR2, UBR4, and UBR5. Mock, beads without peptide conjugation. (E) Semi-
purification of endogenous UBR1/UBR2 from an EF cytoplasmic extract using a peptide-pulldown assay. The precipitates/Phe-peptide beads
complex prepared from cytoplasmic EF extracts were separated on SDS-PAGE and transferred onto a polyvinylidene difluoride membrane,
followed by staining with Coomassie brilliant blue R-250 (Bio-Rad). Anti-UBR1 and -UBR2 immunoblotting confirmed enrichment of UBR1 and
UBR2 (data not shown). (F) Northern blot analysis of UBR4 and -actin using different mouse adult tissues. Total RNA (20 g) was loaded in
each lane. Ethidium bromide-stained ribosomal RNAs are shown as a loading control (bottom panel).
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produced two peptide-mediated chicken antibodies to mouse
UBR4. The peptide bead-bound proteins from testes extracts
were eluted, separated on SDS-PAGE, and blotted with anti-
body against UBR1, UBR2, UBR4, or UBR5. Consistent with
the silver staining data (Fig. 2A), anti-UBR1, -UBR2, and
-UBR4 antibodies detected a 200-kDa doublet (for UBR1
and UBR2) and a 570-kDa band (for UBR4) from precipitates
prepared by bead-conjugated peptides bearing a specific N-
degron but not a stabilizing N-terminal residue (Fig. 2D). Anti-
UBR5 antibody detected a 300-kDa band from precipitates
prepared with a bead-conjugated peptide bearing type 1 N-
degron but not type 2 N-degron or a stabilizing N-terminal
residue (Fig. 2D). These results collectively suggest that UBR1
and UBR2 preferentially bind to type 2 N-degrons, UBR4
binds to type 1 and type 2 N-degrons, while UBR5 binds to
type 1 but not to type 2 N-degrons.
Protein-based pulldown assays (e.g., immunoprecipitation or
GST-pulldown assay) are usually based on affinity between
specific protein sequences or conformation in a protein- or
species-specific manner and thus require appropriate antibod-
ies or DNA manipulation. In contrast, based on the universal
interaction between an E3 (e.g., N-recognin) and a degron
(e.g., N-degron), the peptide pulldown assay may be generally
applied for one-step purification or precipitation of endoge-
nous N-recognins (and maybe other E3s as well with specific
degrons) from a broad spectrum of tissues or species (from
prokaryotes to mammals) as well as for E3-substrate interac-
tion analyses. For example, Fig. 2E shows that elution of Phe-
FIG. 3. (A) Sequence alignment of the UBR box motifs. Conserved Cys and His residues are highlighted (cyan). Indicated by orange highlight
is the Cys residue of Arabidopsis BIG, whose missense mutation perturbs auxin transport (24). Indicated by pink are the residues of S. cerevisiae
UBR1 essential for degradation of type 1 N-end rule substrates (A. Webster, M. Ghislain, and A. Varshavsky, unpublished data). Note that
different organisms contain different sets of UBR box proteins. Prefixes: m, Mus musculus; d, Drosophila melanogaster; a, Arabidopsis thaliana; sc,
Saccharomyces cerevisiae; sp, Schizosaccharomyces pombe, c, Caenorhabditis elegans. Protein sequences listed are m-UBR1 (NP_033487), m-UBR2
(AAQ17202), m-UBR3 (T. Tasaki, Y. T. Kwon, and A. Varshavsky, unpublished data), m-UBR4 (this study), m-UBR5 (AAT28194), m-UBR6
(AAH55343), m-UBR7 (BAC40212), d-UBR1 (NP_573184), d-UBR3 (NP_572426), d-UBR4 (NP_476986), d-UBR5 (P51592), d-UBR6
(AAF54459), d-UBR7 (AAF53607), c-UBR1 (AAB42328), c-UBR3 (AAO38656), c-UBR4 (AAD47122), c-UBR5 (NP_492389), c-UBR6
(AAC48052), c-UBR7 (CAA99920), a-UBR1 (NP_195851), a-UBR4 (NP_186875), a-UBR7 (T08905), sc-UBR1 (P19812), sc-UBR2
(NP_013124), sp-UBR1 (CAB10108), sp-UBR3 (O60152), and sp-UBR7 (Q09329). (B) Locations of the UBR boxes and domains characteristic,
in particular, of E3 Ub ligases in the mouse UBR1 to UBR7 proteins. UBR, UBR box; RING, RING finger; CRD, cysteine-rich domain; HECT,
HECT domain; PHD, plant homeodomain. (C) Phylogenetic relationships of UBR box proteins. The relative evolutional distances between each
UBR box sequence were calculated by a neighbor-joining method. The tree is unrooted and the length of each branch is proportional.
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peptide-bound proteins (captured from EF extracts; 2 mg
total proteins) with an SDS-PAGE sample buffer yields a Coo-
massie quantity (0.1 to 1.0 g) of highly enriched UBR1 and
UBR2 (Fig. 2E).
UBR box family of E3 ubiquitin ligases. The above results
suggest that the mammalian genome encodes at least four
proteins that can bind to type 1 and/or type 2 N-degrons. We
then asked whether these proteins share a common motif in-
volved in recognition of N-degrons. Although UBR4 and
UBR5 showed no significant overall homology to other mouse
proteins, UBR1 to UBR5 contained a putative 70-residue
zinc finger-like motif named the UBR box (Fig. 3A). By using
a sequence alignment program (see Materials and Methods),
we found that the mammalian genome encodes at least seven
of the mouse UBR box proteins termed UBR1 to UBR7 (Fig.
3A and B). Phylogenetic analysis of the UBR box motif se-
quences from yeast to mouse classified them into UBR4,
UBR6 (with an F-box), UBR7 with the PHD (plant homeodo-
main) domain, UBR5 (with the HECT domain), and UBR1/
2/3 (with the RING finger) subfamilies (Fig. 3C).
As described above, UBR1, UBR2, and UBR3 contain the
RING ubiquitylation domain. The 300-kDa UBR5/EDD con-
tains the HECT ubiquitylation domain and the UBA (Ub-
associated) domain (11, 29). UBR6 is a 90-kDa orphan F-box
protein which contains the F-box motif, a feature of degron-
recognizing subunits of modular Ub ligases called SCF (13, 36,
59, 82). The F-box motif is essential for the interaction of an
F-box-containing SCF subunit with the rest of SCF Ub ligase.
SCFs are a large, functionally diverse family of Ub ligases that
differ not only in regard to their F-box subunits but in other
subunits as well (13, 59). The presence of the UBR box in
UBR6 (Fig. 3A and B) and the fact that the previously char-
acterized F-box subunits of SCF Ub ligases function as their
degron-recognizing components suggest that UBR6 may rec-
ognize degrons via its UBR domain, and moreover, that the
corresponding SCF E3 may function as an N-recognin, a con-
jecture to be tested.
UBR7 is a novel 50-kDa protein. It contains a putative PHD
domain that resembles but is distinct from the RING domain.
We used putative because the distinction between RING and
PHD is fairly subtle, and the “true” PHD domain appears not
to be present in the Ub ligases described so far (1, 12, 66).
Thus, it remains to be determined whether the above domain
of UBR7 is a bona fide PHD or, instead, a version of the RING
domain characteristic of a large class of E3 Ub ligases that
includes UBR1 and UBR2. As with the UBR6 protein above,
the co-occurrence, in UBR7, of the UBR box motif and a
(putative) PHD domain suggests that UBR7 is also an E3 Ub
ligase, possibly an N-recognin. Based on these results, we pro-
pose that the UBR box family defines a unique E3 class that
recognizes N-degrons or structurally related molecules, via the
UBR box motif, for Ub-dependent proteolysis or related pro-
cesses.
We also asked whether UBR box proteins that were previ-
ously known or were shown in the present work to be N-
recognins also have such properties in an organism phyloge-
netically distant from mammals. Extracts from the Drosophila
melanogaster D.Mel-2 cell line were subjected to the Phe-pep-
tide pulldown assay, followed by SDS-PAGE of recovered pro-
teins and silver staining. The results (Fig. 4) were in agreement
with the above expectation. Specifically, the Phe-peptide assay
isolated two major species whose sizes were consistent with
their being Drosophila UBR1 (called UBR1 in Drosophila as
well) and UBR4 (called PUSHOVER in Drosophila) (64) (Fig.
4A). The Arg-peptide assay captured, in addition, a protein of
the size of Drosophila UBR5 (HYD) (Fig. 4A), a result con-
sistent with the preferential binding of mouse UBR5 (EDD/
hHYD) to Arg-peptide over Phe-peptide (Fig. 3A). Immuno-
blotting of the same samples with antibody to Drosophila
UBR5 confirmed the recovery of Drosophila UBR5 by the
Arg-peptide assay (Fig. 4B). Although preliminary, these find-
ings suggest that strong sequelogs of mammalian UBR1,
UBR2, UBR4, and UBR5 in phylogenetically distant eu-
karyotes also function as N-recognins, that is, the N-end rule
pathway’s E3 Ub ligases, or their subunits.
Degradation of N-end rule substrates is impaired in cells
deficient in UBR1, UBR2, and UBR4. UBR5 (EDD/hHYD) is
the previously characterized E3 Ub ligase (11, 29, 31, 65)
whose specificity as an N-recognin was discovered in the
present work (Fig. 2A and D). In contrast, there is no pub-
lished evidence (apart from sequence comparisons) about the
Ub ligase activity of either Drosophila PUSHOVER or plant
BIG, the previously characterized strong sequelogs of mam-
malian UBR4 (11, 19, 24, 37, 52, 54, 64, 87). Both the presence
of the UBR box in UBR4 (PUSHOVER/BIG) (Fig. 3A) and
the demonstrated specific binding of UBR4 to destabilizing
N-terminal residues (Fig. 2A to D) strongly suggest that UBR4
is an N-recognin.
To address this issue further, we employed retrovirus-medi-
ated RNAi to construct UBR4RNAi, UBR1/ UBR2/
UBR4RNAi, and UBR1/ UBR2/ luciferase (UBR1/
UBR2/ LucRNAi) stable cell lines (Fig. 5A). Among the four
siRNAs tested (sequences A to D), siRNAs A, B, and D
yielded a strong (80 to 90%) decrease in UBR4 protein as
determined by anti-UBR4 immunoblotting (Fig. 5A), whereas
siRNA C did not yield significant UBR4 silencing. We then
examined the in vivo stability of 70-kDa Sindbis virus RNA
FIG. 4. N-recognins in Drosophila melanogaster. (A) Peptide-pull-
down analysis of Drosophila proteins in D.Mel-2 cells. Cytoplasmic
proteins were precipitated by a bead-conjugated peptide bearing N-
terminal Arg, Phe, or Gly. (B) Peptide-pulldown analysis followed by
Western blot using anti-Drosophila UBR5/HYD antiserum.
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polymerase Tyr-nsP4 (type 2 N-degron, an authentic protein)
and Arg-nsP4 (its mutant bearing a type 1 N-degron) in wild-
type and various UBR protein mutant cells by using pulse-
chase analysis (Fig. 5B and C).
While 1.9% and 10% of Tyr-nsP4 remained after the 2-h
chase in wild-type and UBR1/ UBR2/ cells, 85% of
Tyr-nsP4 remained in two independent UBR1/ UBR2/
UBR4RNAi cell lines under the same condition (Fig. 5B and C
and Table 2, and data not shown). Further, Tyr-nsP4 was
rapidly ubiquitylated in reticulocyte lysates, and its ubiquityla-
tion was specifically inhibited by a dipeptide bearing a type 2
N-degron but not a type 1 N-degron (Fig. 6C). In contrast to
Tyr-nsP4, 1.2%, 6.0%, and 26% of Arg-nsP4 remained in wild-
type, UBR1/ UBR2/, and UBR1/ UBR2/ UBR4RNAi
cells, respectively (Fig. 5B and C), suggesting that there is an
additional N-recognin (e.g., UBR5) other than UBR1, UBR2,
and UBR4 in normally growing mouse EFs.
The degree of stabilization of Tyr-nsP4 and Arg-nsP4 was in
agreement with the degree of UBR4 silencing because they
remained short-lived in UBR1/ UBR2/ LucRNAi control
cells and was only marginally stabilized in UBR1/ UBR2/
UBR4RNAi cell line C, where no significant UBR4 knockdown
was observed (Fig. 5B and C). Further, degradation of these
substrates was not significantly impaired in UBR4RNAi or
UBR1/ UBR2/ cells, suggesting that either UBR4 knock-
down or UBR1/UBR2 knockout is not sufficient to perturb
nsP4 degradation.
Together with our finding that endogenous UBR4 binds to
N-degrons (Fig. 2D), these results collectively implicate UBR4
as a third N-recognin and suggest that there are at least three
mammalian N-recognins that can recognize type 1 and type 2
N-degrons. N-recognin is currently defined as an E3 that can
recognize N-degrons for ubiquitylation. However, since it is
unclear whether UBR4 has a ubiquitylation domain, an N-
FIG. 5. Analysis of the in vivo degradation of Sindbis virus RNA polymerases bearing N-terminal Tyr in wild-type, UBR4RNAi, UBR1/
UBR2/ UBR4RNAi, and UBR1/ UBR2/ LucRNAi stable cell lines. (A) Immunoblot analysis of UBR4 in UBR4RNAi, UBR1/ UBR2/
UBR4RNAi, and UBR1/ UBR2/ LucRNAi stable cell lines. Wild-type (wt) and UBR/ UBR2/ EFs stably expressing UBR4 short-hairpin RNA
(shRNA) were analyzed by immunoblot using anti-UBR4 antibody. Cells were transduced by recombinant retroviruses with four different
short-hairpin RNA sequences (A, B, C, and D) for UBR4 RNAi or firefly luciferase (Luc) and subsequently selected for puromycin resistance.
After drug selection, a pool of colonies was lysed, and UBR4 knockdown efficiency was determined using 5% SDS-PAGE and immunoblotting.
A nonspecific band is indicated by the asterisk as a loading control. Independent immunoblot analysis with isolated colonies gave largely similar
results (data not shown). (B) Pulse-chase analysis of X-nsP4, where X is Met (stabilizing), Arg (type 1 N-degron), or Tyr (type 2 N-degron), in cells
deficient in UBR proteins, singly or in combination. See Fig. 1F for details. (C) Quantitation of the patterns shown in B using PhosphorImager.
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recognin can also be a substrate (N-degron) recognition sub-
unit of an E3 complex.
The relative destabilizing activities of N-terminal residues
have not been characterized extensively in mammalian cells.
Given the N-end rule-dependent proteolysis of Tyr-nsP4, we
next examined the functional interaction of UBR box proteins
with other N-terminal amino acids (Fig. 6A and B and Table
2). In addition to type 1 and type 2 N-degrons, the N-terminal
Ala, Ser, and Thr residues have also been found to confer
metabolic instability on an N-end rule reporter (X-[-galacto-
sidase]) in reticulocyte extract (25), suggesting the existence of
a distinct (type 3) branch of the N-end rule pathway.
As shown in Fig. 6B and Table 2, Thr-nsP4 bearing a puta-
tive type 3 destabilizing N-terminal residue was a long-lived
protein in all genetic backgrounds tested, leaving the problem
of type 3 N-degrons to be addressed in future work. In con-
trast, X-nsP4s bearing N-terminal His (type 1), Leu (type 2), or
Phe (type 2) were short-lived in wild-type EF cells (Fig. 6B and
Table 2). Interestingly, the degradation of His-nsP4, Leu-nsP4,
and Phe-nsP4 was significantly slower in UBR1/ UBR2/
cells, suggesting that participation of N-recognins other than
UBR1 and UBR2 in targeting the above destabilizing residues
may be relatively minor. Taken together with other data above,
these findings (Fig. 6A and B and Table 2) suggest that the
type 1 and type 2 substrate-binding sites of UBR1, UBR2,
UBR4, UBR5, and other (to be discovered and/or verified)
N-recognins may recognize specific destabilizing N-terminal
residues of a given type (either 1 or 2) differentially. The
relative destabilizing activities of the N-terminal residues
tested, with X-nsP4 as a reporter, are summarized in Tables 1
and 2.
UBR1, UBR2, and UBR4 participate in degradation of
HIV-1 integrase. The 32-kDa integrase of human immunode-
ficiency virus is produced in infected cells through its excision,
by HIV-encoded protease, from the 160-kDa HIV Gag-Pol
polyprotein and subsequently mediates the insertion of the
(reverse-transcribed) viral genome into a host’s chromosome
(8). We have previously shown that HIV-1 integrase (Phe-
integrase), which naturally bears N-terminal Phe, a type 2
destabilizing residue, is short-lived in human HEK-293T cell
FIG. 6. Degradation kinetics of X-nsP4 bearing N-terminal His, Phe, Gly, Leu, and Thr in various UBR mutant cells. (A) Pulse-chase analysis
of X-nsp4, where X is Met or Gly (stabilizing), His (type 1 N-degron), Leu or Phe (type 2 N-degron), or Thr (type3 N-degron), in cells deficient
in UBR proteins, singly or in combination. (B) Quantitation of the patterns shown in A using PhosphorImager. S, stabilizing; 1/2, type 1/2
N-degron; 3, type 3 N-degron. (C) Ubiquitylation assay of X-nsP4 in rabbit reticulocyte lysate. Upper panel: X-nsP4 proteins (where X is Met, Arg,
or Tyr) were expressed and translationally labeled with biotin using transcription-translation-coupled reticulocyte lysates with or without 2 mM
dipeptide as indicated. The proteasome inhibitor MG132 (5 M) was also present, to accumulate ubiquitylated proteins. After 30 min of
incubation, ubiquitylated proteins were immunoprecipitated with anti-Ub antibody, followed by SDS-PAGE of precipitated proteins and detection
of biotinylated proteins (see Materials and Methods). Lower panel: X-nsP4 proteins (where X is Met, Arg, or Tyr) were in vitro translated as above
without MG132 and a portion of the reticulocyte lysates was loaded, followed by Western blotting with horseradish peroxidase-conjugated
streptavidin.
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line, and its N-terminal Phe is a part of an N-degron that
mediates the bulk of Phe-integrase degradation in these cells
(56). However, specific E3s that mediate Phe degradation have
not been characterized. We examined steady-state levels of
X-integrase proteins (where X is Met, Gly, Arg, His, Phe, and
Leu) in wild-type, UBR1/ UBR2/ LucRNAi, and UBR1/
UBR2/ UBR4RNAi cells. In the expression system used (Fig.
7A), the EGFP (fluorescent) protein reference is expressed
from the PCMV promoter, while an X-integrase reporter is
expressed from an internal ribosome entry site as part of the
Ub-X-integrase fusion that is cotranslationally cleaved by deu-
biquitylating enzymes in vivo to yield X-integrase.
In wild-type cells, the levels of X-integrase bearing either
type 1 or type 2 N-terminal residues (including Phe, its natural
N-terminal residue) were significantly lower than the levels of
X-integrases bearing stabilizing N-terminal residues, such as
Met or Gly (Fig. 7B). Furthermore, the levels of normally
short-lived X-integrase proteins were significantly increased in
UBR1/ UBR2/ UBR4RNAi cells in comparison to
UBR1/ UBR2/ LucRNAi cells (Fig. 7B), suggesting that
UBR1, UBR2, and UBR4 participate in the in vivo targeting of
these integrases. However, treatment of cells with MG132, a
proteasome inhibitor, significantly increased the levels of all
the integrase proteins tested, including Met-integrase, even in
UBR1/ UBR2/ UBR4RNAi cells, indicating the presence of
yet another E3(s) that targets N-degrons and/or an internal
degron of integrase.
We then attempted to evaluate the in vivo stability of X-
integrase in wild-type and UBR protein mutant cells using
pulse-chase analysis. Due to low in vivo labeling efficiency, we
humanized the codons of integrase (see accession number
AF422697) to increase translation efficiency and fused the re-
sulting ORF to the C terminus of Ub to generate N-terminal
Phe (Fig. 7C). When normalized to the levels of -galactosi-
dase (encoded by a cotransfected plasmid), the amount of
35S-labeled Phe-integrase remaining after 40 min of chase was
increased from 14% in wild-type cells to 32% in UBR1/
UBR2/ UBR4RNAi cells (Fig. 7D and E).
To further examine the in vitro proteolysis of X-integrase
(where X is Arg, Phe, or Met), X-integrase was expressed and
labeled with [35S]methionine in transcription-translation-cou-
pled rabbit reticulocyte lysates. In agreement with the above
results, it was rapidly destroyed in reticulocyte extract and
could be stabilized by Phe-Ala (type 2) dipeptide but not by
either Arg-Ala (type 1) dipeptide or Ala-Phe (Fig. 7F). These
results collectively suggest that HIV-1 Phe-integrase can be at
least in part targeted through the recognition of its N-degron
by a set of cellular E3 systems, including UBR1, UBR2, and
UBR4.
To test whether the in vivo integration of HIV-1 into cellular





Initial decayb of X-nsP4 (%)
Wild-type EFs UBR1/ UBR2/ EFs
No treatment UBR4RNAi D No treatment UBR4RNAi D UBR4RNAi C LucRNAi
Stabilizing Met 0 0 0 0 0 0
Gly 0 0 8 0
Type 1 Arg 86c 92 54c 17 14 72
His 71 0 23 6
Type 2 Tyr 74c 65 36c 18 0 29
Phe 80 23 32 19
Leu 67 4 16 0
Type 3 Thr 0 0 20 0
a Initial decay (ID12, %) of X-nsP4 at the end of a 12-min pulse was calculated as follows: ID12 	 100  {[X-nsP4]0/[Met-nsP4]0}  100 where [X-nsP4]0 denotes
the amount of 35S-labeled X-nsP4 at time 0 (at the end of the 12-min pulse) after normalization as described for Fig. 1G.
b Zero indicates that the relative amount of 35S-labeled X-nsP4 at time zero was higher than that of Met-nsP4 in the same cell line.
c Average value using the Phosphorlmager data from Fig. 1G and Fig. 5C.






Wild-type EFs UBR1/ UBR2/ EFs
No treatment UBR4RNAi D No treatment UBR4RNAi D UBR4RNAi C LucRNAi







Type 1 Arg 42 
120b 34 72 40 32
His 36 50 
120 50
Type 2 Tyr 40 37 38 
120 56 32
Phe 38 54 
120 39
Leu 40 55 113 41
Type 3 Thr 61 52 99 48
a Half-life (t
0.5
0–60, min) of X-nsP4 between 0 and 60 min of chase was calculated as follows: t
0.5
0–60 	 50 (%)  60 (min)/SD0–60 (%). Subsequent decay (SD0–60, %)
denotes the ratio of the amount of a labeled X-nsP4 at 60 min of chase to that of the same labeled X-nsP4 at time zero. SD0–60 	 100  {[X-nsP4]60/[X-nsP4]0} 
100, where [X-nsP4]60 was the amount of 35S-labeled X-nsP4 at 60 min and [X-nsP4]0 was as described in Table 1, footnote a.
b The amount of 35S-labeled Arg-nsP4 at time zero in UBR4RNAi EFs is significantly low (Fig. 5C and Table 1).
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DNA is impaired in cells that lack specific N-recognins, wild-
type, UBR1/ UBR2/, and UBR1/ UBR2/ UBR4RNAi
cells were infected with GFP-marked recombinant HIV-1, and
the integration of HIV-1 was assessed using fluorescence-ac-
tivated cell sorting. The knockout or knockdown of UBR1,
UBR2, and UBR4 marginally impaired HIV-1 infection
(L. C. F. Mulder, T. Tasaki, Y. T. Kwon, and M. A. Muesing,
unpublished data), suggesting that the inhibition of these three
molecules is not sufficient to block HIV-1 integration. How-
ever, it remains to be tested whether HIV-1 infectivity is sig-
nificantly decreased in human cells deficient in UBR1, UBR2,
and UBR4 and if other UBR box proteins play an additional
role in HIV-1 integrase turnover.
DISCUSSION
We have previously shown that two functionally overlapping
mammalian E3s, termed UBR1 and UBR2, can recognize N-
degrons for N-end rule-dependent proteolysis (45–47). Given
the retention of this pathway in single-mutant UBR1/ and
UBR2/ mouse cell lines (46) (see the introduction), we here
constructed mice lacking both UBR1 and UBR2 (Fig. 1B and
FIG. 7. HIV-1 integrase is an in vivo substrate of UBR box proteins. (A) Schematic diagram for a bicistronic mRNA producing EGFP and
X-integrase (where X is Met, Gly, Arg, His, Phe, or Leu) used in B. (B) The steady-state level of X-integrase and EGFP, expressed in wild-type,
UBR1/ UBR2/ LucRNAi, and UBR1/ UBR2/ UBR4RNAi cells, was determined using immunoprecipitation and Western analysis with
anti-integrase antibody. Cells were treated with MG132 (10 M) or solvent (dimethyl sulfoxide [DMSO]). N-terminal amino acids of integrase are
indicated on the top. Ig-H and Ig-L, mouse immunoglobulin G heavy and light chains, respectively. The expression of the reference protein EGFP
was determined using immunoblotting with anti-GFP antibody for an input control. (C) A pcDNA3-based bicistronic construct expressing
Ub-X-integrase and hrGFP used in D to F. Since hrGFP was poorly expressed in EFs, LacZ-V5 was coexpressed as a reference protein.
(D) Pulse-chase analysis of Met- and Phe-integrases in wild-type and UBR1/ UBR2/ UBR4RNAi cells. Cells were labeled for 30 min with
[35S]methionine/cysteine, followed by a chase for 0, 20, and 40 min in the presence of cycloheximide, preparation of extracts, immunoprecipitation
with a combination of anti-integrase and anti-V5 antibodies, followed by SDS-PAGE and autoradiography. (E) Quantitation of the patterns shown
in D using a PhosphorImager. (F) Degradation of Met- and Phe-integrases was analyzed using in vitro transcription/translation-coupled rabbit
reticulocyte lysate in the presence of MG132 (5 M) or dipeptide (2 mM) as indicated, and [35S]methionine-labeled proteins were analyzed by
SDS-PAGE, followed by autoradiography. Met-integrase is indeed slightly stabilized by MG132 or the type 1 dipeptide Arg-Ala (but not by the
type 1 dipeptide Phe-Ala), suggesting that a minor population of Met-integrase may be modified (e.g., oxidation) into an unknown structure that
mimics a weak type 1 N-degron.
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C) and demonstrate that UBR1/ UBR2/ cells retain sig-
nificant degradation activities for model N-end rule substrates
(Fig. 1F and G). This result is unexpected because the S.
cerevisiae N-end rule pathway is mediated only by one N-
recognin, the 225-kDa UBR1 (6).
To identify an additional N-recognin, that is, an E3 Ub ligase
that recognizes N-degrons, we performed an affinity-based pro-
teomic approach using synthetic peptides bearing N-degrons.
We report here that four mammalian proteins, UBR1, UBR2,
a 570-kDa novel protein termed UBR4, and a 300-kDa E3
called EDD (termed UBR5 in this study), can bind to type 1
and/or type 2 N-degrons and that the mammalian genome
encodes at least seven proteins (termed UBR1 to UBR7) shar-
ing a 70-amino-acid zinc finger-like domain termed the UBR
box motif.
A remarkable feature of UBR box proteins is that they all
(except for UBR4) contain specific body signatures (e.g.,
RING in UBR1, UBR2, and UBR3; HECT in UBR5; F-box in
UBR6; PHD in UBR7) found in E3 or a substrate recognition
subunit of an E3 complex, suggesting that the UBR box family
defines a unique E3 class, most likely N-recognin. Is the UBR
box motif the only signature that defines N-recogin? The rel-
atively small (45 kDa) Arabidopsis PRT1 Ub ligase has recently
been shown to act as an N-recognin that recognizes a subset of
type 2 N-degrons (70). However, this RING finger E3 does not
contain the “canonical” UBR box motif (Fig. 2A). Interest-
ingly, we found that the ZZ domain of PRT1 weakly resembles
a part of the UBR box motif (T. Tasaki and Y. T. Kwon,
unpublished data), suggesting that variants of the UBR box
motif may exist and recognize distinct subsets of N-degrons or
structurally related molecules.
Data from pulse-chase analysis indicate that normally short-
lived Tyr-nsP4 is almost completely stabilized in UBR1/
UBR2/ UBR4RNAi cells, whereas the same protein is only
marginally stabilized in UBR1/ UBR2/ cells (Fig. 5B and
C). Together with peptide pulldown assays indicating that
UBR4 can bind to a type 2 N-degron (Fig. 2), in vivo degra-
dation assays indicate that UBR4 is a third N-recognin (in
addition to UBR1 and UBR2). Notably, UBR1/ UBR2/
UBR4RNAi cells retained a weak but detectable activity for
degradation of Arg-nsP4 bearing a type 1 N-degron (Fig. 5B
and C), predicting the presence of a fourth N-recognin mainly
specific for type 1 substrates. Our biochemical data indicate
that mouse and Drosophila UBR5 proteins can bind to a type
1 (but not type 2) N-degron (Fig. 2A and D and Fig. 4A and B),
suggesting that UBR5 is likely to be a type 1-specific N-recog-
nin responsible for the residual type 1 N-recognin activities
observed in UBR1/ UBR2/ UBR4RNAi cells.
During proteomic screening of N-recognins, we did not de-
tect UBR3, UBR6, or UBR7, suggesting that these UBR box
proteins may not bind efficiently to N-degrons under these
conditions. Consistent with this observation, mouse UBR3 ex-
pressed in S. cerevisiae did not bind to N-degrons (T. Tasaki,
Y. T. Kwon, and A. Varshavsky, unpublished data) to which
UBR1 and UBR2 readily bound under the same conditions
(46). Nonetheless, we do not exclude the possibility that UBR6
and UBR7 may not have been expressed in normally growing
mouse EFs or required a posttranslational modification (e.g.,
phosphorylation, sumoylation, or neddylation) to be active as
N-recognins. In mammals, N-terminal Ala, Ser, and Thr have
been reported to be destabilizing through their recognition by
an unidentified E3 called E3 with a size of200 kDa (25, 28).
However, our attempts to capture such an E3 using type 3
peptide beads were unsuccessful.
Sindbis virus RNA polymerase nsP4 and HIV-1 integrase
have been suggested as substrates of the N-end rule pathway
(18, 56). Our results (Fig. 5 to 7) provide the functional con-
nection between these substrates and their cellular E3s and
suggest that the N-end rule pathway may participate in degra-
dation of a broad range of viral proteins bearing N-degrons
and thus for their viral life cycle as well. Given the conserved
nature of interactions between N-degrons and E3, we exam-
ined the identity of the N-terminal amino acids of lentiviral
integrases (including HIV-1 integrase) and alphaviral RNA
polymerases (including Sindbis polymerase). As summarized
in Fig. 8, all of the viral proteins that we have examined thus
far bore type 2 N-degrons, suggesting that the in vivo stabilities
of these viral proteins (and thus their life cycles as well) may be
regulated through their N-degron-mediated proteolysis by a
set of cellular UBR box proteins.
Mammalian UBR box proteins (UBR1 to UBR7) have their
apparent functional homologs in other organisms (Fig. 2A and
C). Therefore, the known functions of the UBR box family
may reveal new pathways in which the N-end rule pathway
participates. As a founding UBR family member, UBR1 is
solely responsible for the S. cerevisiae N-end rule pathway (6).
S. cerevisiae UBR1 appears to have been duplicated during
evolution into UBR1 and UBR2 in mammals but not in the fly
or plants (see Fig. 3A). UBR1 and UBR2 have similar sizes
(200 kDa) and sequences (46% identity), and N-terminal rec-
ognition specificities (45–47), and we anticipate that UBR1
and UBR2 cooperate in at least some biological processes.
Consistent with this expectation is the previous finding that
UBR1 and UBR2 form a stable complex with RECQL4 be-
longing to the RecQ helicase family that is implicated in the
Rothmund-Thomson and Rapadilino syndromes (88).
We also recently found that UBR1 and UBR2 cooperate for
in vivo degradation of RGS4 and RGS5, negative regulators of
the G protein-coupled receptor (GPCR) signaling pathway
(M. J. Lee, T. Tasaki, J. Y. An, K. Moroi, I. Davydov, and Y. T.
Kwon, submitted for publication). Genetic and biochemical
studies have implicated UBR1 and/or UBR2 in fat metabo-
lism, male meiosis, female-specific development (in mice),
peptide transport, and chromosome stability (in S. cerevisiae)
(46, 47, 62, 74). UBR3 is a previously uncharacterized protein,
and UBR3/ neonatal offspring die in association with defects
in milk suckling (T. Tasaki, A. Varshavsky, and Y. T. Kwon,
unpublished data). Notably, we found that UBR3 is promi-
nently expressed in the olfactory cortex of the brain, suggesting
that UBR3 may be critical for the olfactory GPCR signaling
pathway. Further characterization of UBR3/ mice is under
way. S. cerevisiae UBR2 (termed UBR3 in this study since it is
a much stronger sequelog of mammalian UBR3 than UBR1/
UBR2) was recently found to mediate the degradation of
Rpn4, the transcriptional factor that regulates proteasome
genes (81).
UBR4 has an extraordinary size (570 kDa) and appears to
be a structural and functional homolog of Arabidopsis BIG
(560 kDa) and Drosophila PUSHOVER (560 kDa) (19, 24, 37,
52, 54, 64, 87) (Fig. 3B). In contrast to other UBR box pro-
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teins, UBR4 lacks a known ubiquitylation domain. It is to be
determined whether UBR4 is itself an E3 or a substrate rec-
ognition subunit of an unknown E3 complex. Arabidopsis BIG/
a-UBR4 has been identified as two independent gene muta-
tions which resulted in altered responses of hormone and light
and severely impaired auxin transport (24, 37), suggesting its
essential role in regulation of the function and transport of
auxin, a major plant hormone (19, 24, 37, 52, 54). Drosophila
PUSHOVER/UBR4 was originally identified as a calmodulin-
binding protein (86). Genetic studies implicated PUSHOVER
in male reproduction (64), nonrecombinant chromosome seg-
regation in the female meiosis (67), synaptic transmission in
photoreceptor cells (86), and perineurial glial growth by me-
diating signals from amn-encoded neuropeptide (87). Taken
together, UBR4 and its homologs appear to regulate the sig-
naling pathways in response to extrinsic stimuli such as hor-
mones or neurotransmitters.
The 300-kDa UBR5 protein is a previously characterized
mammalian E3 known as EDD (E3 identified by differential
display) or hHYD (11, 29, 31, 65). UBR5 is a sequelog of the
Drosophila tumor suppressor gene hyperplastic disks (55).
UBR5 ubiquitylates TopBP1 for proteolysis (31) and interacts
with CIB (calcium- and integrin-binding protein) in a DNA
damage-dependent manner (29). TopBP1 is a member of the
newly emerging BRCT (BRCA1 carboxyl-terminal) domain
proteins implicated in DNA damage checkpoint and/or DNA
repair pathways (90). CIB interacts with DNA-dependent pro-
tein kinase which functions in the DNA damage pathway (84).
UBR5 is often amplified in cancer and is implicated in cancer
progression (16). More recently, knockout mice lacking EDD/
UBR5 were found to be impaired in yolk sac vascularization
(65). Drosophila HYD/d-UBR5 is required for fertility and
functions as a tumor suppressor by controlling cell prolifera-
tion (55). Through experiments with a Drosophila cell line and
the X-peptide pulldown assay, we demonstrated that, as would
be expected from the findings with mouse UBR5, the insect
UBR5 (HYD) protein is also, operationally, an N-recognin
(see Results). Taken together, UBR5 and its homologs appear
to be involved in DNA repair, cancer progression, and angio-
genesis.
UBR6 is a 90-kDa orphan F-box protein with no apparent
overall homology to other mouse proteins. The F-box protein
is a component of the SCF E3 Ub ligase complex and contains
two domains: an F-box motif that binds Skp1 for assembly into
the SKP1/CUL1 complex and a carboxy-terminal domain that
recognizes substrates (4, 82). The UBR box of UBR6 thus
appears to be a substrate recognition domain for a putative
SCFUBR6-E3 complex. UBR6 also contains the CASH domain,
either a predicted or observed right-handed -helix structure
that is shared by many carbohydrate-binding proteins and
sugar hydrolases (15). A splice valiant of human UBR6 was
implicated in the human genetic disease called vitiligo (50).
UBR7 is a 50-kDa novel protein containing the PHD motif,
a RING finger-like domain (26, 53). Various PHD proteins are
known to be involved in chromatin-mediated transcriptional
regulation (26). Overexpression of MLO2, an apparent UBR7
homolog in Schizosaccharomyces pombe, showed an asymmet-
rical segregation of chromosomes (34).
In summary, our identification of the UBR box E3 family
unveils an enormous range of processes that are potentially
mediated by the N-end rule pathway. It is to be investigated
which of these functions are mediated by N-degron-dependent
proteolysis.
Based on our findings, we propose a model in which the
UBR box motif binds to N-degrons and other N-degron-like
FIG. 8. Lentiviral integrases and alphaviral RNA polymerases
commonly bear type 2 N-degron. (A, B) Alignment of inferred N-
terminal sequences of mature lentiviral integrases and nonlentiviral
integrases (A) and alphaviral RNA polymerases (B). Conserved type 2
N-degrons are indicated by blue highlighting and an asterisk. Other
conserved residues are indicated by orange highlighting. The protein
sequences (accession number, organism) listed are: BIV_106 (P19560,
bovine immunodeficiency virus isolate 106), EIAV_CL22 (P32542,
equine infectious anemia virus clone CL22), FIV_TM2 (P31822, feline
immunodeficiency virus isolate TM2), CAEV_CORK (P33459, ca-
prine arthritis encephalitis virus strain CORK), OLV_SA_OMV
(P16901, ovine lentivirus strain SA-OMVV), SRLV, (AAS18421,
Small ruminant lentivirus), visna_KV17 (P35956, Visna lentivirus
strain KV1772), HIV-1_HXB2 (P04585, HIV-1 HXB2 isolate), HIV-
1_YU-2 (P35963, HIV-1 YU-2 isolate), HIV-2_GHAN (P18042,
HIV-2 isolate GHANA-1), HIV-2_KR (Q74120, HIV-2 isolate KR),
SIV_AGM155 (P27973, simian immunodeficiency virus AGM155 iso-
late), SIV_GRI-1 (Q02836, simian immunodeficiency virus isolate
AGM), HumERK (CAA76879, human endogenous retrovirus K),
MMTV (GNMVMM, mouse mammary tumor virus), SRV2
(AAD43256, simian retrovirus 2), WMSV (NP_041261, woolly monkey
sarcoma virus), MPMV (GNLJMP, Mason-Pfizer monkey virus),
STLV2 (CAA74901, simian T-lymphotropic virus 2), WEEV
(P_818936, western equine encephalomyelitis virus), EEEV (S72349,
eastern equine encephalitis virus), VEEV (AAD14556, Venezuelan
equine encephalitis virus), SFV (NP_463457, Semliki forest virus),
Mayaro (NP_579968, Mayaro virus), Sindbis (P03317, Sindbis virus),
Sleeping_d (NP_740656, sleeping disease virus), Igbo_Ora
(NP_740715, Igbo Ora virus), SPD (NP_740638, salmon pancreas dis-
ease virus), Aura (NP_819013, aura virus), Middelburg (P03318,
Middleburg virus), and Ross_river (P13887, Ross River virus strain
NB5092).
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small molecules (e.g., amino acid derivatives, neurotransmit-
ters, or hormones) to alter the protein ubiquitylation activity of
the UBR box-containing E3 protein. Consistent with this
model, a missense mutation of Arabidopsis BIG and UBR4
that perturbs auxin transport and growth was mapped to one of
the conserved Cys residues within the UBR box motif (24)
(Fig. 3A, shaded orange). Further, genetic analyses identified
several S. cerevisiae UBR1 residues that are required for deg-
radation of N-recognin substrates, and some of these critical
residues (Cys145, Val146, Gly173, and Asp176 of S. cerevisiae
UBR1) were a part of the UBR box motif (Fig. 3A, shaded
pink) (A. Webster, M. Ghislain, and A. Varshavsky, unpub-
lished data).
If the above conjecture proves correct, the known substrate-
binding properties of UBR box proteins, including their being
N-recognins, are likely to be a subset of their specificity rep-
ertoires. S. cerevisiae UBR1 contains three substrate-binding
sites, two of which, type 1 and type 2, recognize (bind to)
destabilizing N-terminal residues in proteins or short peptides
(6, 22, 44, 74, 78). These sites target specific proteins bearing
N-degrons for ubiquitylation, such as the separase-produced
fragment of SCC1, a cohesin subunit (62). Remarkably, these
two sites also function as nutritional/homeostatic sensors,
through the same ability to bind polypeptides (including short
peptides) with destabilizing N-terminal residues. This binding
allosterically activates the third substrate-binding site of yeast
UBR1, which recognizes an internal (non-N-terminal) degron
of CUP9, a conditionally short-lived transcriptional repressor.
CUP9 down-regulates several genes, including PTR2, which
encodes a peptide transporter (10, 22, 74). The resulting pos-
itive-feedback circuit, in which imported peptides can activate
the UBR1-dependent degradation of a repressor that down-
regulates their import, allows S. cerevisiae to sense the pres-
ence of extracellular peptides and to react by accelerating their
uptake (22, 74).
The conjectured diversity of recognition specificities of
UBR-box E3s, if coupled with their differential, spatiotempo-
rally controlled expression patterns, may underlie the already
large and still expanding set of functions of the N-end rule
pathway and other Ub-dependent pathways that involve UBR-
box proteins.
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